Trust & Proof: Ozempic (Novo Nordisk) – Signal Evidence & AI Readability

{
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "url": "https://www.ozempic.com/",
    "name": "Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes",
    "headline": "For adults with type 2 diabetes, along with diet and exercise, to improve blood sugar. Talk to your health care professional about which Ozempic® option is right for you.",
    "description": "Ozempic® (semaglutide) is a GLP-1 RA type 2 diabetes treatment that is available in an injectable pen or pill. Read Important Safety Information, including Boxed Warning.",
    "copyrightYear": 2026,
    "copyrightHolder": {
        "@type": "Organization",
        "name": "Novo Nordisk",
        "url": "https://www.novonordisk-us.com"
    },
    "audience": {
        "@type": "MedicalAudience",
        "audienceType": "Patient"
    },
    "about": [
        {
            "@type": "Drug",
            "name": "Ozempic®",
            "nonProprietaryName": "semaglutide",
            "activeIngredient": "semaglutide",
            "alternateName": [
                "Ozempic® (semaglutide) injection",
                "Ozempic® (semaglutide) tablets",
                "Ozempic® pen",
                "Ozempic® pill"
            ],
            "drugClass": "GLP-1 (glucagon-like peptide-1) receptor agonist",
            "dosageForm": [
                "injection",
                "tablets"
            ],
            "administrationRoute": [
                "subcutaneous injection",
                "oral"
            ],
            "doseSchedule": [
                {
                    "@type": "DoseSchedule",
                    "frequency": "once-weekly",
                    "doseUnit": "mg",
                    "doseValue": [
                        "[DEPTH_TRUNCATED]",
                        "[DEPTH_TRUNCATED]",
                        "[DEPTH_TRUNCATED]"
                    ],
                    "targetPopulation": "adults with type 2 diabetes"
                },
                {
                    "@type": "DoseSchedule",
                    "frequency": "once-daily",
                    "doseUnit": "mg",
                    "doseValue": [
                        "[DEPTH_TRUNCATED]",
                        "[DEPTH_TRUNCATED]"
                    ],
                    "targetPopulation": "adults with type 2 diabetes"
                }
            ],
            "availableStrength": [
                {
                    "@type": "DrugStrength",
                    "strengthValue": 0.5,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                },
                {
                    "@type": "DrugStrength",
                    "strengthValue": 1,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                },
                {
                    "@type": "DrugStrength",
                    "strengthValue": 2,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                },
                {
                    "@type": "DrugStrength",
                    "strengthValue": 4,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                },
                {
                    "@type": "DrugStrength",
                    "strengthValue": 9,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                }
            ],
            "prescriptionStatus": "https://schema.org/PrescriptionOnly",
            "prescribingInfo": [
                "https://www.novo-pi.com/ozempic.pdf",
                "https://www.novo-pi.com/ozempictablets.pdf"
            ],
            "warning": [
                "Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.",
                "Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people"
            ],
            "pregnancyWarning": "It is not known if Ozempic® will harm your unborn baby or pass into your breast milk. You should stop using Ozempic® at least 2 months before you plan to become pregnant",
            "image": {
                "@type": "ImageObject",
                "name": "Ozempic® logo",
                "contentUrl": "https://ozempic.com/content/dam/diabetes-patient/ozempic/images/25_01/header-combination-logo.png"
            },
            "manufacturer": {
                "@type": "Organization",
                "name": "Novo Nordisk Inc.",
                "url": "https://www.novonordisk-us.com/home.html",
                "contactPoint": {
                    "@type": "ContactPoint",
                    "contactType": "patient assistance",
                    "telephone": "1-866-310-7549",
                    "description": "Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs."
                }
            }
        },
        {
            "@type": "MedicalCondition",
            "name": "type 2 diabetes",
            "alternateName": [
                "diabetes"
            ]
        },
        {
            "@type": "MedicalCondition",
            "name": "heart disease",
            "alternateName": [
                "known heart disease",
                "cardiovascular disease"
            ]
        },
        {
            "@type": "MedicalCondition",
            "name": "chronic kidney disease"
        },
        {
            "@type": "MedicalTherapy",
            "guideline": [
                "Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic® (semaglutide) tablets 4 mg or 9 mg are prescription medicines used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes",
                "Ozempic® injection is used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease, to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease",
                "Ozempic® tablets are used to reduce the risk if major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who are at high risk for these events"
            ],
            "adverseOutcome": {
                "0": "The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.",
                "1": "inflammation of your pancreas (pancreatitis). Stop using Ozempic® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes may feel the pain from your abdomen to your back",
                "2": "changes in vision. Tell your health care provider if you have changes in vision during treatment with Ozempic®",
                "3": "low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Ozempic® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery",
                "4": "dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your health care provider right away if you have nausea, vomiting, or diarrhea that does not go away",
                "_items_truncated": true
            },
            "contraindication": [
                "Do not use Ozempic® if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).",
                "Do not use Ozempic® if: you have had a serious allergic reaction to semaglutide or any of the ingredients in Ozempic®."
            ],
            "recognizingAuthority": {
                "@type": "Organization",
                "name": "U.S. Food and Drug Administration",
                "alternateName": "FDA",
                "url": "https://www.fda.gov/"
            }
        }
    ],
    "breadcrumb": {
        "@type": "BreadcrumbList",
        "itemListElement": [
            {
                "@type": "ListItem",
                "position": 1,
                "item": {
                    "@id": "https://www.ozempic.com/",
                    "name": "Home"
                }
            }
        ]
    },
    "hasPart": {
        "0": {
            "@type": "WebPageElement",
            "headline": "For adults with type 2 diabetes, along with diet and exercise, to improve blood sugar",
            "text": "Discover 2 ways to take Ozempic® and which uses may be right for you"
        },
        "1": {
            "@type": "WebPageElement",
            "headline": "Only Novo Nordisk manufactures FDA-approved semaglutide medicines like Ozempic®"
        },
        "2": {
            "@type": "WebPageElement",
            "headline": "For adults with type 2 diabetes, Ozempic® in a pen is the GLP-1 with the most FDA-approved uses. All uses may not apply. Ask your health care professional."
        },
        "3": {
            "@type": "WebPageElement",
            "headline": "In adults with type 2 diabetes, Ozempic® in a pen lowers blood sugar and A1C, along with diet and exercise",
            "potentialAction": {
                "@type": "Action",
                "name": "Learn about A1C",
                "target": "https://ozempic.com/ozempic-pen/what-is-ozempic-pen.html#bloodSugar"
            }
        },
        "4": {
            "@type": "WebPageElement",
            "headline": "In adults who also have heart disease, Ozempic® in a pen lowers the risk of major cardiovascular events such as stroke, heart attack, or death",
            "potentialAction": {
                "@type": "Action",
                "name": "Discover the impact",
                "target": "https://ozempic.com/ozempic-pen/what-is-ozempic-pen.html#cardiovascular"
            }
        },
        "_items_truncated": true
    },
    "_truncated": true,
    "_original_size": 10393
}

{
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "url": "https://www.ozempic.com/ozempic-pen/what-is-ozempic-pen.html",
    "name": "What is Ozempic® Pen? | Ozempic® (semaglutide)",
    "headline": "What Is Ozempic® (semaglutide) injection?",
    "description": "Learn about the benefits of the Ozempic® (semaglutide) pen, a once-weekly GLP-1 RA injection for type 2 diabetes. Read Important Safety Information, including Boxed Warning.",
    "copyrightYear": 2026,
    "copyrightHolder": {
        "@type": "Organization",
        "name": "Novo Nordisk",
        "url": "https://www.novonordisk-us.com"
    },
    "audience": {
        "@type": "MedicalAudience",
        "audienceType": "Patient"
    },
    "specialty": {
        "@type": "MedicalSpecialty",
        "name": "Endocrine"
    },
    "about": [
        {
            "@type": "Drug",
            "name": "Ozempic®",
            "nonProprietaryName": "semaglutide",
            "activeIngredient": "semaglutide",
            "alternateName": [
                "Ozempic® (semaglutide) injection",
                "Ozempic® pen"
            ],
            "availableStrength": [
                {
                    "@type": "DrugStrength",
                    "strengthValue": 0.5,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                },
                {
                    "@type": "DrugStrength",
                    "strengthValue": 1,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                },
                {
                    "@type": "DrugStrength",
                    "strengthValue": 2,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                }
            ],
            "dosageForm": [
                "injection"
            ],
            "administrationRoute": [
                "subcutaneous injection"
            ],
            "prescriptionStatus": "https://schema.org/PrescriptionOnly",
            "prescribingInfo": [
                "https://www.novo-pi.com/ozempic.pdf"
            ],
            "drugClass": "GLP-1 (glucagon-like peptide-1) receptor agonist",
            "doseSchedule": {
                "@type": "DoseSchedule",
                "frequency": "once-weekly",
                "doseUnit": "mg",
                "doseValue": [
                    0.5,
                    1,
                    2
                ],
                "targetPopulation": "Adults with type 2 diabetes"
            },
            "pregnancyWarning": "It is not known if Ozempic® will harm your unborn baby or pass into your breast milk. You should stop using Ozempic® at least 2 months before you plan to become pregnant",
            "warning": [
                "Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.",
                "Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people"
            ],
            "image": {
                "@type": "ImageObject",
                "name": "Ozempic® logo",
                "contentUrl": "https://ozempic.com/content/dam/diabetes-patient/ozempic/images/25_01/header-combination-logo.png"
            },
            "manufacturer": {
                "@type": "Organization",
                "name": "Novo Nordisk",
                "url": "https://www.novonordisk-us.com",
                "logo": "https://www.ozempic.com/content/dam/diabetes-patient/ozempic/images/novo-nordisk-logo.png",
                "contactPoint": {
                    "@type": "ContactPoint",
                    "contactType": "patient assistance",
                    "telephone": "1-866-310-7549",
                    "description": "Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs."
                }
            }
        },
        {
            "@type": "MedicalCondition",
            "name": "type 2 diabetes"
        },
        {
            "@type": "MedicalCondition",
            "name": "heart disease",
            "alternateName": [
                "known heart disease",
                "cardiovascular disease"
            ]
        },
        {
            "@type": "MedicalCondition",
            "name": "chronic kidney disease"
        },
        {
            "@type": "MedicalTherapy",
            "guideline": [
                "Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used: along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes; to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease; to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabete"
            ],
            "adverseOutcome": {
                "0": "The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.",
                "1": "inflammation of your pancreas (pancreatitis). Stop using Ozempic® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes may feel the pain from your abdomen to your back",
                "2": "changes in vision. Tell your health care provider if you have changes in vision during treatment with Ozempic®",
                "3": "low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Ozempic® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery",
                "4": "dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your health care provider right away if you have nausea, vomiting, or diarrhea that does not go away",
                "_items_truncated": true
            },
            "contraindication": [
                "Do not use Ozempic® if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).",
                "Do not use Ozempic® if: you have had a serious allergic reaction to semaglutide or any of the ingredients in Ozempic®."
            ],
            "recognizingAuthority": {
                "@type": "Organization",
                "name": "U.S. Food and Drug Administration",
                "alternateName": "FDA",
                "url": "https://www.fda.gov/"
            }
        }
    ],
    "breadcrumb": {
        "@type": "BreadcrumbList",
        "itemListElement": [
            {
                "@type": "ListItem",
                "position": 1,
                "item": {
                    "@id": "https://www.ozempic.com/",
                    "name": "Home"
                }
            },
            {
                "@type": "ListItem",
                "position": 2,
                "item": {
                    "@id": "https://www.ozempic.com/ozempic-pen/",
                    "name": "Ozempic® Pen"
                }
            },
            {
                "@type": "ListItem",
                "position": 3,
                "item": {
                    "@id": "https://www.ozempic.com/ozempic-pen/what-is-ozempic-pen.html",
                    "name": "What Is Ozempic® Pen?"
                }
            }
        ]
    },
    "hasPart": {
        "0": {
            "@type": "WebPageElement",
            "headline": "What Is Ozempic® (semaglutide) Injection?",
            "text": "Ozempic® is the only GLP-1 approved for all of these uses for adults with type 2 diabetes:"
        },
        "1": {
            "@type": "WebPageElement",
            "headline": "Ozempic® is proven to lower blood sugar and A1C when used along with diet and exercise."
        },
        "2": {
            "@type": "WebPageElement",
            "headline": "Ozempic® lowers the risk of major cardiovascular events such as stroke, heart attack, or death in adults who also have heart disease."
        },
        "3": {
            "@type": "WebPageElement",
            "headline": "Ozempic® lowers the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease."
        },
        "4": {
            "@type": "WebPageElement",
            "headline": "Ozempic® may also help you lose weight. Ozempic® is not a weight-loss drug."
        },
        "_items_truncated": true
    },
    "_truncated": true,
    "_original_size": 10929
}

{
    "@context": "https://schema.org",
    "@type": "MedicalWebPage",
    "url": "https://ozempic.com/ozempic-pill/what-is-ozempic-pill.html",
    "name": "What is Ozempic® Pill? | Ozempic® (semaglutide) pill",
    "headline": "What Is Ozempic® (semaglutide) Pill?",
    "description": "Learn about the benefits of the Ozempic® (semaglutide) pill, a once-weekly GLP-1 RA pill for type 2 diabetes. Read Important Safety Information, including Boxed Warning.",
    "copyrightYear": 2026,
    "copyrightHolder": {
        "@type": "Organization",
        "name": "Novo Nordisk",
        "url": "https://www.novonordisk-us.com"
    },
    "audience": {
        "@type": "MedicalAudience",
        "audienceType": "Patient"
    },
    "specialty": {
        "@type": "MedicalSpecialty",
        "name": "Endocrine"
    },
    "about": [
        {
            "@type": "Drug",
            "name": "Ozempic®",
            "nonProprietaryName": "semaglutide",
            "activeIngredient": "semaglutide",
            "alternateName": [
                "Ozempic® (semaglutide) pill",
                "Ozempic® pill"
            ],
            "availableStrength": [
                {
                    "@type": "DrugStrength",
                    "strengthValue": 1.5,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                },
                {
                    "@type": "DrugStrength",
                    "strengthValue": 4,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                },
                {
                    "@type": "DrugStrength",
                    "strengthValue": 9,
                    "strengthUnit": "mg",
                    "activeIngredient": "semaglutide"
                }
            ],
            "dosageForm": [
                "tablet"
            ],
            "administrationRoute": [
                "oral"
            ],
            "prescriptionStatus": "https://schema.org/PrescriptionOnly",
            "prescribingInfo": [
                "https://www.novo-pi.com/ozempictablets.pdf"
            ],
            "drugClass": "GLP-1 (glucagon-like peptide-1) receptor agonist",
            "doseSchedule": {
                "@type": "DoseSchedule",
                "frequency": "once-daily",
                "doseUnit": "mg",
                "doseValue": [
                    1.5,
                    4,
                    9
                ],
                "targetPopulation": "Adults with type 2 diabetes"
            },
            "pregnancyWarning": "It is not known if Ozempic® will harm your unborn baby or pass into your breast milk. You should stop using Ozempic® at least 2 months before you plan to become pregnant",
            "warning": [
                "Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people"
            ],
            "image": {
                "@type": "ImageObject",
                "name": "Ozempic® logo",
                "contentUrl": "https://ozempic.com/content/dam/diabetes-patient/ozempic/images/25_01/header-combination-logo.png"
            },
            "manufacturer": {
                "@type": "Organization",
                "name": "Novo Nordisk",
                "url": "https://www.novonordisk-us.com",
                "logo": "https://www.ozempic.com/content/dam/diabetes-patient/ozempic/images/novo-nordisk-logo.png",
                "contactPoint": {
                    "@type": "ContactPoint",
                    "contactType": "patient assistance",
                    "telephone": "1-866-310-7549",
                    "description": "Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs."
                }
            }
        },
        {
            "@type": "MedicalCondition",
            "name": "type 2 diabetes"
        },
        {
            "@type": "MedicalCondition",
            "name": "heart disease",
            "alternateName": [
                "known heart disease",
                "cardiovascular disease"
            ]
        },
        {
            "@type": "MedicalTherapy",
            "guideline": [
                "Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic® (semaglutide) tablets 4 mg or 9 mg are prescription medicines used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes",
                "Ozempic® tablets are used to reduce the risk if major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who are at high risk for these events"
            ],
            "adverseOutcome": [
                "The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.",
                "inflammation of your pancreas (pancreatitis). Stop using Ozempic® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes may feel the pain from your abdomen to your back",
                "changes in vision. Tell your health care provider if you have changes in vision during treatment with Ozempic®",
                "low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Ozempic® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery",
                "dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your health care provider right away if you have nausea, vomiting, or diarrhea that does not go away",
                "severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Ozempic®. Tell your health care provider if you have stomach problems that are severe or will not go away",
                "serious allergic reactions. Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat",
                "gallbladder problems. Gallbladder problems have happened in some people who take Ozempic®. Tell your health care provider right away if you get symptoms which may include: pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools",
                "food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Ozempic® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your health care providers that you are taking Ozempic® before you are scheduled to have surgery or other procedures"
            ],
            "contraindication": [
                "Do not use Ozempic® if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).",
                "Do not use Ozempic® if: you have had a serious allergic reaction to semaglutide or any of the ingredients in Ozempic®."
            ],
            "recognizingAuthority": {
                "@type": "Organization",
                "name": "U.S. Food and Drug Administration",
                "alternateName": "FDA",
                "url": "https://www.fda.gov/"
            }
        }
    ],
    "breadcrumb": {
        "@type": "BreadcrumbList",
        "itemListElement": [
            {
                "@type": "ListItem",
                "position": 1,
                "item": {
                    "@id": "https://www.ozempic.com/",
                    "name": "Home"
                }
            },
            {
                "@type": "ListItem",
                "position": 2,
                "item": {
                    "@id": "https://ozempic.com/ozempic-pill/",
                    "name": "Ozempic® Pill"
                }
            },
            {
                "@type": "ListItem",
                "position": 3,
                "item": {
                    "@id": "https://ozempic.com/ozempic-pill/what-is-ozempic-pill.html",
                    "name": "What Is Ozempic® Pill?"
                }
            }
        ]
    },
    "hasPart": [
        {
            "@type": "WebPageElement",
            "headline": "Lower your A1C with Ozempic® pill",
            "text": "Ozempic® pill can lower blood sugar and A1C, along with diet and exercise"
        },
        {
            "@type": "WebPageElement",
            "headline": "Reduce cardiovascular risk with Ozempic® pill",
            "text": "Adults with type 2 diabetes are at greater risk for major cardiovascular events, such as stroke, heart attack, or death. Ozempic® pill lowers the risk of major cardiovascular events, such as stroke, heart attack, or death, in adults with type 2 diabetes who also are at high risk for these events."
        },
        {
            "@type": "WebPageElement",
            "headline": "Ozempic® pill may help you lose weight",
            "text": "Ozempic® pill is not a weight-loss drug."
        },
        {
            "@type": "WebPageElement",
            "headline": "Talk to your health care professional about your treatment goals",
            "text": "Talk to your health care professional to see if Ozempic® is right for you.",
            "potentialAction": {
                "@type": "Action",
                "name": "Download discussion guide",
                "target": "https://ozempic.com/content/dam/ozempic/site/patient/documents/Questions-About-Starting-Ozempic.pdf"
            }
        }
    ]
}